Get started
GEN ILACGEN ILACGEN ILAC

GEN ILAC

No trades
See on Supercharts
Overview
Financials News Discussions Technicals Seasonals

GENIL chart


Full chart

Key stats


Market capitalization
‪43.23 B‬ TRY
Dividend yield (indicated)
0.28%
Price to earnings Ratio (TTM)
318.6
Basic EPS (TTM)
0.5 TRY
Net income (FY)
‪148.68 M‬ TRY
Revenue (FY)
‪14.74 B‬ TRY
Shares float
‪67.44 M‬
Beta (1Y)
0.50

About GEN ILAC


Sector
Health Technology
Industry
Pharmaceuticals: Major
Headquarters
Ankara
Website
genilac.com.tr
Founded
1998
ISIN
TREGENL00024
FIGI
BBG011QRRP85
Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. It offers drugs against endocrinology, neurology, onco-haematology , nephrology, and metabolism disorders. Its products include Cajex, Contra-K, Epamor, Ferint, Genium, Genkort, Intrafen, Ilopera, Novils, Parigen, Pleksor, and Vorigen. The company was founded in 1998 and is headquartered in Ankara, Turkey.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GENIL news



Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as GENIL.

Frequently Asked Questions


The current price of GENIL is 145.7 TRY — it has increased by 1.11% in the past 24 hours. Watch GEN ILAC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIST exchange GEN ILAC stocks are traded under the ticker GENIL.
GENIL stock has risen by 4.07% compared to the previous week, the month change is a −7.78% fall, over the last year GEN ILAC has showed a 119.26% increase.
GENIL reached its all-time high on Mar 3, 2025 with the price of 166.5 TRY, and its all-time low was 11.8 TRY and was reached on Aug 5, 2021. View more price dynamics on GENIL chart.
See other stocks reaching their highest and lowest prices.
GENIL stock is 3.70% volatile and has beta coefficient of 0.50. Track GEN ILAC stock price on the chart and check out the list of the most volatile stocks — is GEN ILAC there?
Today GEN ILAC has the market capitalization of ‪43.66 B‬, it has increased by 10.32% over the last week.
Yes, you can track GEN ILAC financials in yearly and quarterly reports right on TradingView.
GENIL net income for the last quarter is ‪43.63 M‬ TRY, while the quarter before that showed ‪111.77 M‬ TRY of net income which accounts for −60.96% change. Track more GEN ILAC financial stats to get the full picture.
GEN ILAC dividend yield was 0.33% in 2024, and payout ratio reached 80.63%. The year before the numbers were 2.37% and 73.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GEN ILAC EBITDA is ‪1.45 B‬ TRY, and current EBITDA margin is 9.56%. See more stats in GEN ILAC financial statements.
Like other stocks, GENIL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GEN ILAC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GEN ILAC technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GEN ILAC stock shows the buy signal. See more of GEN ILAC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.